May 28, 2019
The U.S. Supreme Court declined Tuesday to review a decision by the Seventh Circuit that tossed a $3 million verdict in favor of the widow of a Reed Smith LLP partner who killed himself while taking a generic version of GlaxoSmithKline's antidepressant Paxil.
December 20, 2018
The widow of a Reed Smith LLP partner who had been taking a GlaxoSmithKline antidepressant when he killed himself asked the U.S. Supreme Court on Wednesday to review the case against the drugmaker, which was initially held liable for the death until a Seventh Circuit appeals panel threw out the verdict.
September 20, 2018
The Seventh Circuit on Thursday refused to reconsider its decision to overturn a $3 million verdict blaming GlaxoSmithKline for the suicide of a Reed Smith partner who had been taking a generic version of its Paxil drug.
September 06, 2018
The Seventh Circuit panel that overturned a $3 million verdict against GlaxoSmithKline for not including a suicide warning on its Paxil drug committed a "grave error" by ignoring some pieces of evidence and taking others completely out of context, the widow suing the pharmaceutical giant said Wednesday in a rehearing request.
August 22, 2018
The Seventh Circuit ruled in favor of GlaxoSmithKline on Wednesday in the drug company's appeal of a $3 million jury award to the widow of a Reed Smith LLP partner who committed suicide while taking a generic version of Paxil, saying federal law barred the pharmaceutical company from adding a warning about the risk of suicide in adults.
July 06, 2018
The widow of a Reed Smith LLP partner who committed suicide while taking a generic version of GlaxoSmithKline LLC's Paxil told the Seventh Circuit on Friday it shouldn't wait for an upcoming U.S. Supreme Court ruling to decide whether the drug company can be held liable for her husband's death.
May 30, 2018
Judges on a Seventh Circuit panel considering GlaxoSmithKline's appeal after it was sued by the widow of a Reed Smith LLP attorney who committed suicide while taking a generic form of Paxil had questions about the case's implications for the economy as a whole during oral arguments Wednesday.
May 15, 2018
GlaxoSmithKline LLC told the Seventh Circuit that a recent opinion in the West Virginia Supreme Court of Appeals bolsters its argument that branded drugmakers shouldn't be held responsible for the labels on generic alternatives.
March 21, 2018
The widow of a Reed Smith LLP attorney who committed suicide after taking a generic version of GlaxoSmithKline's antidepressant Paxil told the Seventh Circuit on Tuesday that a decision last week by Massachusetts' top appellate court torpedoes the company's appeal of her $3 million jury verdict.
March 15, 2018
GlaxoSmithKline on Wednesday urged the Seventh Circuit to toss a $3 million verdict in favor of the widow of a Reed Smith attorney who committed suicide after taking the generic of its antidepressant Paxil, saying the U.S. Food and Drug Administration had barred it from warning of the drug's suicide risks.